Drawing for NOVOPEX

USPTO serial 87050533

NOVOPEX

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
TRUSILO, KELLY JEAN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NOVOPEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David M. Perry

DAVID M. PERRY BLANK ROME LLPONE LOGAN SQUARE8TH FLOORPHILADELPHIA, PA 19103

Goods and services

ClassDescriptionStatusFirst use
001Chemical products, namely, pharmaceutical excipients; chemical preparations, chemical substances and chemical materials for use in the manufacture of pharmaceutical excipients; chemical products, namely, pharmaceutical excipients in the nature of coatings, fillers, disintegrants, flavors, vehicles, emollients, colorants, solubilizers, stabilizers, antiadherents, binders, glidants, lubricants, preservatives, sorbents, sweeteners, diluents, solvents, buffering agents, anti-oxidants, wetting agents, anti-foaming agents, thickening agents, flavoring agents, sweetening agentsACTIVE—
005Medical preparations and chemico-pharmaceutical preparations for use as pharmaceutical excipients in the nature of coatings, fillers, disintegrants, flavors, vehicles, emollients, colorants, solubilizers, stabilizers, antiadherents, binders, glidants, lubricants, preservatives, sorbents, sweeteners, diluents, solvents, buffering agents, anti-oxidants, wetting agents, anti-foaming agents, thickening agents, flavoring agents, sweetening agentsACTIVE—
035Business management and consulting services, including sourcing and supplier management related to pharmaceutical excipient industryACTIVE—
039Packaging services, transportation logistics, storage; transport, packaging and storage of goods; consultancy in relation to the afore-mentioned services, all related to pharmaceutical excipientsACTIVE—
040Custom manufacture and assembly services, in the field of pharmaceuticals and pharmaceutical excipients; custom preparation of premixes and blends in the field of pharmaceutical excipients; consultancy in relation to the afore-mentioned servicesACTIVE—
042Quality audits; analytical laboratory services; product testing, product quality testing; testing of pharmaceuticals and of pharmaceutical excipients; testing for pharmaceutical quality needs; product approval and quality release in relation to pharmaceutical products and pharmaceutical excipients; testing, authentication and quality control; scientific and technological services, namely, scientific research, analysis, testing, and design services in the field of pharmaceuticals and pharmaceutical excipients, and research and design relating thereto; services in relation to quality control, namely, Good Manufacturing Practice (GMP) documentation; science and technology services, namely, scientific research, analysis, testing, and design services in the field of pharmaceuticals and pharmaceutical excipients for compliance with pharmaceutical regulations; chemical laboratory services, including formulation support; consultancy in relation to the afore-mentioned services, all related to pharmaceutical excipient industry and pharmaceutical excipientsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 12, 2017MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 12, 2017ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 8, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 13, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 13, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 24, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 9, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 6, 2016ALIEASSIGNED TO LIE—
Jul 26, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 26, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Jul 26, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 26, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 26, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 24, 2016DOCKASSIGNED TO EXAMINER—
Jun 2, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 30, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance